{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T22:47:27Z","timestamp":1770331647096,"version":"3.49.0"},"reference-count":34,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2003,4,8]],"date-time":"2003-04-08T00:00:00Z","timestamp":1049760000000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2003,4]]},"abstract":"<jats:p> <jats:bold>BACKGROUND<\/jats:bold>: Currently, individuals donating whole blood and cellular components are not screened for hepatitis A (HA). However, transfusion\u2010transmitted HA can occur, albeit very rarely. Although infection is typically mild and self\u2010limited, it may be catastrophic in a small percentage of cases. Two cases of HA transmission from a single donation to two patients with subsequent variable morbidity are reported.<\/jats:p><jats:p> <jats:bold>CASE REPORTS<\/jats:bold>: A 50\u2010year\u2010old, asymptomatic, volunteer blood donor made a whole\u2010blood donation. He was found to have HA 18 days later. When notified, the donor center initiated a recall of the components produced from the donated unit. However, the RBCs and FFP had already been transfused. Subsequently, both recipients developed HA as documented by IgM anti\u2010HA serology. The RBC recipient was a 49\u2010year\u2010old woman, transfused after a hysterectomy, who was found to have HA at the time of unit recall (20 days after transfusion). Her condition required the use of medical disability leave. The FFP was infused to a 52\u2010year\u2010old female cardiac surgical patient. Her course was marked by multiple complications, including postoperative development of mild hepatic dysfunction. After testing negative for HA, hepatitis B, and hepatitis C (24 days after transfusion), she suffered a second bout of more severe hepatic dysfunction and was documented to have HA at Day 55 after transfusion. Evaluation of both recipients' close contacts revealed no evidence for exposure to HA by any route other than transfusion.<\/jats:p><jats:p> <jats:bold>CONCLUSION<\/jats:bold>: HA can be transmitted by transfusion of units obtained from asymptomatic, infectious donors. Two patients contracted HA from components obtained from a single whole\u2010blood donation. The RBC recipient had a typical self\u2010limited course of HA. The FFP recipient developed HA of relatively delayed onset. Both recovered from HA.<\/jats:p>","DOI":"10.1046\/j.1537-2995.2003.00342.x","type":"journal-article","created":{"date-parts":[[2004,12,29]],"date-time":"2004-12-29T20:58:38Z","timestamp":1104353918000},"page":"536-540","source":"Crossref","is-referenced-by-count":19,"title":["Transmission of hepatitis A via WBC\u2010reduced RBCs and FFP from a single donation"],"prefix":"10.1111","volume":"43","author":[{"given":"A. Hafeez","family":"Diwan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James R.","family":"Stubbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary E.","family":"Carnahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,4,8]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-198911000-00007"},{"key":"e_1_2_5_3_2","first-page":"681","volume-title":"Principles of transfusion medicine","author":"Rossi EC","year":"1996"},{"key":"e_1_2_5_4_2","unstructured":"Petz LD Swisher SN Kleinman S Spence RK Strauss RG editors. Clinical practice of transfusion medicine. 3rd ed. New York: Churchill Livingstone; 1996:850."},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5520(05)70123-9"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1994.tb01290.x"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1997.37297203527.x"},{"key":"e_1_2_5_8_2","unstructured":"Department of Health and Human Services Food and Drug Administration. Application of nucleic acid testing to blood borne pathogens and emerging technologies. OBRR\/CBER\/FDA workshop. Bethesda (MD): The Department; 2001 Dec 4\u20105. Transcript available from:http:\/\/www.fda.gov\/cber\/minutes\/workshop\u2010min.htm."},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.182.4116.1026"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.8.2497"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s007050050280"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(92)90545-U"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.3928\/0090-4481-19910801-09"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.80.9.1091"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198002213020804"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1993.tb121865.x"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01641196"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1086\/513757"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/161.4.647"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/167.3.567"},{"key":"e_1_2_5_21_2","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/jama.1970.03170190035005","article-title":"Viral hepatitis: new light on an old disease.","volume":"212","author":"Krugman S","year":"1970","journal-title":"JAMA"},{"key":"e_1_2_5_22_2","unstructured":"Purcell RH Feinstone SM Ticehurst JR et al. Hepatitis A virus. In: Vyas GN Dienstag JL Hoofnagle JH editors. Viral hepatitis and liver disease. Orlando (FL): Grune and Stratton 1984:9."},{"key":"e_1_2_5_23_2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jama.1967.03120180053006","article-title":"Infectious hepatitis: evidence for two distinctive clinical, epidemiological, and immunological types of infection.","volume":"200","author":"Krugman S","year":"1967","journal-title":"JAMA"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1998.38698326337.x"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1053\/jinf.2000.0781"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0163-4453(90)93652-9"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199202000-00012"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890400108"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.10124"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1086\/315701"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2002.00183.x"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3148.2001.00310.x"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1246-7820(00)80009-9"},{"key":"e_1_2_5_34_2","doi-asserted-by":"crossref","first-page":"6621","DOI":"10.1128\/JVI.72.8.6621-6628.1998","article-title":"The human homolog of HAVcr\u20101 codes for a hepatitis A virus cellular receptor.","volume":"72","author":"Feigelstock P","year":"1998","journal-title":"J Virol"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2000.40101153.x"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1537-2995.2003.00342.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1537-2995.2003.00342.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1537-2995.2003.00342.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T05:56:22Z","timestamp":1697262982000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1537-2995.2003.00342.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["10.1046\/j.1537-2995.2003.00342.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1537-2995.2003.00342.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,4]]}}}